phenytoin has been researched along with Cranial Nerve II Diseases in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
" This study tested the hypothesis that sodium channel blockade with phenytoin would result in neuroprotection of retinal ganglion cells (RGCs) and optic nerve axons in an experimental model of glaucoma." | 7.73 | Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. ( Hains, BC; Waxman, SG, 2005) |
" This study tested the hypothesis that sodium channel blockade with phenytoin would result in neuroprotection of retinal ganglion cells (RGCs) and optic nerve axons in an experimental model of glaucoma." | 3.73 | Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. ( Hains, BC; Waxman, SG, 2005) |
"A 19-year old man with cryptogenic simple partial and secondary generalized epilepsy developed blurred vision and xanthopsia after phenytoin loading for status epilepticus." | 3.72 | Acute visual dysfunction following phenytoin-induced toxicity. ( Deleu, D; Shenoy, R; Thakral, A, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thakral, A | 1 |
Shenoy, R | 1 |
Deleu, D | 1 |
Hains, BC | 1 |
Waxman, SG | 2 |
Hamard, H | 1 |
Desbordes, JM | 1 |
Fern, R | 1 |
Ransom, BR | 1 |
Stys, PK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Cohort Study of Association Between Steady State Phenytoin Treatment and Better Clinical Parameters of Glaucoma[NCT00739154] | 200 participants (Anticipated) | Observational | 2008-11-30 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for phenytoin and Cranial Nerve II Diseases
Article | Year |
---|---|
[Iatrogenic pathology of the optic nerve].
Topics: Adrenal Cortex Hormones; Antiprotozoal Agents; Chloramphenicol; Contraceptives, Oral; Ethambutol; Fe | 1982 |
3 other studies available for phenytoin and Cranial Nerve II Diseases
Article | Year |
---|---|
Acute visual dysfunction following phenytoin-induced toxicity.
Topics: Adult; Anticonvulsants; Color Perception; Epilepsy; Evoked Potentials, Visual; Humans; Male; Optic N | 2003 |
Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Topics: Administration, Oral; Animals; Axons; Cell Count; Cell Survival; Disease Models, Animal; Glaucoma; I | 2005 |
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Topics: Action Potentials; Animals; Axons; Carbamazepine; Diazepam; Dose-Response Relationship, Drug; Female | 1993 |